Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. BMO Capital analyst notes ...
MM&M54m
Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years
Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.
New schizophrenia drug ‘could change the lives of millions of people’
A groundbreaking new drug to treat schizophrenia called Cobenfy, owned by pharmaceutical firm Bristol Myers Squibb, has been ...
kalkinemedia1m
New Era in Schizophrenia Care with Bristol Myers Squibb's COBENFY Approval
Highlights,Bristol Myers Squibb's shares rose following the FDA's approval of COBENFY, the first new schizophrenia treatment ...
These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, Wynn, HP Inc., Acadia Healthcare, and More
Stocks traded mixed Friday after the Federal Reserve’s preferred inflation measure, the personal consumption expenditures ...
Dow hits record high on tame inflation report that also boosts small caps
U.S.-listed shares of Chinese firms such as Alibaba (NYSE: BABA) rose 2.8%, PDD Holdings climbed 4.4% and NetEase (NASDAQ: ...
Stock market today: Wall Street drifts around its records as Chinese stocks close a monster week
U.S. stock indexes are drifting around their records Friday as hopes hold that the economy can pull off the rare feat of ...